Beranda › Demensia › Massachusetts
Uji klinis Demensia di Massachusetts
17 studi untuk Demensia mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0080, Watertown
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06976203Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
- Vitalix, Worcester
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06052254Making Connections Thru Music
- Hopeful Aging, Winchester
- The Hearthstone Institute, LLC, Winchester
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 103 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06079216The BRAIN App (Phase 2 SBIR)
- Hopeful Aging, Winchester
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06298474Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
- Massachusetts General Hospital, Boston
Menerima pesertaStudi observasional
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06052397Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- VA Boston Healthcare System, Boston
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04262206A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
Menerima pesertaFase 1
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Boston Center for Memory, Newton
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06976216Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
- Hebrew Rehabilitation Center, Roslindale
Menerima peserta
Usia 65 hingga 90 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06821568A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Boston Center for Memory, Newton
- MedVadis Research Corporation, Waltham
Menerima pesertaFase 3
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- ActivMed Practices and Research, Methuen
Menerima pesertaFase 2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT07094516Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Massachusetts General Hospital, Co-Enrolling through ABC-DS Only, Boston
Menerima pesertaStudi observasional
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04165109Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston
Menerima pesertaFase 2
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 12 Feb 2026 · NCT06489548Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- Hinda and Arthur Marcus Institute for Aging Research, Boston
Menerima peserta
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 12 Jan 2026 · NCT05661084Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
- Hebrew SeniorLife, Boston
Menerima peserta
Usia 60 hingga 106 · Semua jenis kelamin · Diperbarui 6 Jan 2026 · NCT05950607Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- McLean Hospital, Belmont
Menerima pesertaStudi observasional
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 6 Nov 2025 · NCT05245903Assess Fibrin in Brains With AD/ADRD
- Massachusetts General Hospital, Boston
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 30 Okt 2025 · NCT05336695Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.